V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001492 | 330000840 | 1.7 | 14.8 | Neo-adjuvant (N) | 2013-10-31 | 2013-10-31 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330004957 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001493 | 330000840 | null | null | Curative (C) | 2013-04-24 | 2013-11-05 | NB HRNBL-1 BUMEL MAT | 02 | Y | 330004957 | NOT MATCHED |
| 330001494 | 330000841 | 1.62 | 58.85 | Neo-adjuvant (N) | 2013-10-31 | 2013-11-14 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330004962 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001495 | 330000841 | 1.1 | 0 | Curative (C) | null | 2017-01-23 | Trial Unspecified | 01 | N | 330004962 | TRIAL |
| 330001496 | 330000842 | 1.22 | 60.2 | Curative (C) | 2015-09-30 | 2015-09-30 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 330004967 | NOT MATCHED |
| 330001497 | 330000843 | 0 | 44 | Curative (C) | 2016-10-21 | 2016-10-21 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 330004971 | NOT MATCHED |
| 330001498 | 330000844 | 1.7 | 74 | Curative (C) | 2017-09-29 | 2017-10-25 | Cisplatin 7 day | 2 | N | 330004974 | CISPLATIN |
| 330001499 | 330000844 | 0 | 66.4 | Curative (C) | 2016-11-15 | 2016-11-27 | NB HRNBL-1 Isotretinoin | N | N | 330004974 | NOT MATCHED |
| 330001500 | 330000845 | 0 | 71.4 | Curative (C) | 2017-07-07 | 2017-07-10 | CISPLATIN + ETOPOSIDE + Mitotane | N | N | 330004985 | NOT MATCHED |
| 330001501 | 330000846 | 1.8 | 59 | null | 2017-03-13 | 2017-04-17 | Cisplatin | 02 | Y | 330004992 | CISPLATIN |
| 330001502 | 330000847 | 1.5 | 59.1 | Neo-adjuvant (N) | null | 2016-11-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005001 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001503 | 330006493 | 1.6 | null | Neo-adjuvant (N) | 2016-04-18 | 2016-04-18 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005004 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001504 | 330006493 | null | null | Neo-adjuvant (N) | 2016-05-23 | 2016-05-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005004 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001505 | 330000848 | 1.75 | 25.7 | Curative (C) | 2013-04-24 | 2013-05-18 | Cisplatin | N | null | 330005015 | CISPLATIN |
| 330001506 | 330000848 | 1.53 | null | Curative (C) | 2016-04-20 | 2016-05-13 | Cisplatin | N | Y | 330005015 | CISPLATIN |
| 330001507 | 330000849 | 1.81 | 84 | Curative (C) | 2017-02-27 | 2017-03-06 | Cisplatin | 02 | N | 330005017 | CISPLATIN |
| 330001508 | 330000850 | 1.78 | 27.8 | Curative (C) | 2016-02-12 | 2016-03-15 | Cisplatin 7 day | N | Y | 330005019 | CISPLATIN |
| 330001509 | 330000851 | 1.64 | 58.7 | Curative (C) | 2017-07-26 | 2017-08-02 | Cisplatin | null | Y | 330005030 | CISPLATIN |
| 330001510 | 330000852 | 1.78 | 80.5 | Curative (C) | 2014-12-18 | 2015-01-11 | Cisplatin 7 day | N | null | 330005035 | CISPLATIN |
| 330001511 | 330000853 | 1.74 | 123.2 | Curative (C) | 2015-12-10 | 2015-12-31 | Cisplatin 7 day | N | Y | 330005037 | CISPLATIN |
| 330001512 | 330000853 | null | 35.9 | Curative (C) | null | 2017-01-06 | Cisplatin 7 day | N | Y | 330005037 | CISPLATIN |
| 330001513 | 330000853 | 1.82 | null | Neo-adjuvant (N) | 2017-04-23 | 2017-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005037 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001514 | 330000853 | 1.63 | 10.1 | Curative (C) | null | 2014-11-17 | Cisplatin 7 day | N | N | 330005037 | CISPLATIN |
| 330001515 | 330000854 | 1.73 | 80.8 | Neo-adjuvant (N) | 2016-07-24 | 2016-07-29 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330005054 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001519 | 330000856 | 1.56 | 55.3 | Curative (C) | 2015-11-03 | 2015-11-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005070 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001520 | 330000857 | 1.6 | 69.5 | Curative (C) | 2014-08-04 | 2014-08-07 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 2 | N | 330005074 | NOT MATCHED |
| 330001521 | 330000858 | 1.8 | null | Curative (C) | 2015-11-10 | 2015-11-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330005075 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001522 | 330000859 | 1.64 | 63.4 | Curative (C) | 2017-02-13 | 2017-03-09 | Cisplatin 7 day | N | N | 330005076 | CISPLATIN |
| 330001523 | 330000860 | 1.59 | 81 | Curative (C) | 2017-10-21 | 2017-10-29 | Cisplatin | null | Y | 330005077 | CISPLATIN |
| 330001524 | 330000861 | 1.54 | 8 | Neo-adjuvant (N) | null | 2014-10-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005078 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001525 | 330000862 | null | 60.2 | Curative (C) | 2015-11-17 | 2015-11-23 | EW EuroEwing 2012 Arm B VDC | 1 | Y | 330005086 | TRIAL |
| 330001526 | 330006497 | null | 123 | Curative (C) | 2017-10-10 | 2017-10-10 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330005088 | NOT MATCHED |
| 330001527 | 330006497 | 1.68 | 0 | Neo-adjuvant (N) | 2014-06-13 | 2014-06-16 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005088 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001528 | 330006497 | 1.71 | 77.2 | Curative (C) | 2014-10-13 | 2014-10-13 | NB HRNBL | 02 | Y | 330005088 | NOT MATCHED |
| 330001529 | 330000863 | 1.85 | 15.3 | Curative (C) | 2013-08-28 | 2013-09-12 | Cisplatin | N | Y | 330005091 | CISPLATIN |
| 330001530 | 330000864 | 1.73 | 87.5 | Palliative (P) | 2014-07-11 | 2014-07-15 | Trial Unspecified | 01 | N | 330005092 | TRIAL |
| 330001531 | 330000865 | 1.8 | 54 | Curative (C) | 2013-12-02 | 2013-12-02 | Trial Unspecified | Y | null | 330005102 | TRIAL |
| 330001532 | 330000866 | null | null | Curative (C) | 2016-04-23 | 2016-04-23 | LCH guideline | Y | N | 330005103 | NOT MATCHED |
| 330001533 | 330000866 | null | null | Curative (C) | 2016-12-23 | 2016-12-29 | STS Rhabdo RMS 2005 | N | N | 330005103 | NOT MATCHED |
| 330001534 | 330000867 | 1.8 | null | Neo-adjuvant (N) | 2017-08-05 | 2017-08-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005108 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001535 | 330006499 | 1.67 | 53.1 | Curative (C) | 2017-09-11 | 2017-10-12 | Cisplatin | N | N | 330005110 | CISPLATIN |
| 330001536 | 330006499 | 1.79 | 96.3 | Curative (C) | 2014-03-01 | 2014-03-14 | Cisplatin 7 day | 02 | N | 330005110 | CISPLATIN |
| 330001537 | 330006499 | 1.8 | 22.7 | null | 2017-04-21 | 2017-04-21 | Trial Unspecified | 02 | null | 330005110 | TRIAL |
| 330001538 | 330000868 | 1.8 | 72.4 | null | 2014-06-10 | 2014-07-07 | Cisplatin 7 day | N | Y | 330005129 | CISPLATIN |
| 330001539 | 330000869 | 1.7 | 67.6 | Adjuvant (A) | 2015-11-20 | 2015-12-14 | Cisplatin | null | N | 330005132 | CISPLATIN |
| 330001540 | 330000869 | 1.62 | 54.4 | Curative (C) | 2018-02-03 | 2018-03-06 | Cisplatin | null | Y | 330005132 | CISPLATIN |
| 330001541 | 330000869 | null | 16.1 | Curative (C) | 2018-06-19 | 2018-06-22 | CNS GCT II Non Germin - Std PEI | 02 | N | 330005132 | NOT MATCHED |
| 330001542 | 330000869 | null | 64.3 | Curative (C) | 2017-04-15 | 2017-04-16 | EW EuroEwing 2012 Arm B VDC | N | null | 330005132 | TRIAL |
| 330001543 | 330000869 | 1.63 | 60.6 | Curative (C) | 2014-07-01 | 2014-07-30 | Cisplatin 7 day | N | Y | 330005132 | CISPLATIN |
| 330001545 | 330006501 | 1.63 | 103 | Adjuvant (A) | 2014-06-29 | 2014-07-17 | Cisplatin | N | Y | 330005153 | CISPLATIN |